Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Vasc Surg. 2017 May 27;66(2):423–432. doi: 10.1016/j.jvs.2017.02.057

Table IV.

Technical predictors of perioperative stroke and major adverse events (MAEs)

Predictor Stroke, No. (%) P value MAE, No. (%) P value
Type of EPD .745 .0955a
  Accunetb 3/158 (1.9)c 3/158 (1.9)
  Emboshield/NAV6b 4/198 (2) 13/198 (6.6)
  Others (including Emboshield) 5/240 (2) 16/240 (6.7) .0291d
Type of stent .7449 .3827
  ACCULINKb 4/209 (1.9) 7/209 (3.4)
  Xactb 4/155 (2.6) 10/155 (6.5)
  Others 1/42 (2.4) 2/42 (4.8)
Stents, No. 1 1
  1 9/383 (2.4) 18/383 (4.7)
  >1 0/24 1/24 (4.2)
Stent length .426 .7871
  ≤30 mm 3/119 (2.5)c 4/119 (3.4)c
  >30 mm 4/284 (1.4) 13/284 (4.6)
PTA before EPD
  Yes 2/22 (9.1) .0791 2/22 (9.1) .2721
  No 7/387 (1.8) 17/387 (4.4)
PTA before stenting
  Yes 6/244 (2.5) .7451 12/244 (4.9) .7501
  No 3/165 (1.8) 7/165 (4.2)
PTA after stenting
  Yes 9/341 (2.6) .3666 19/341 (5.6) .0536
  No 0/68 0/68

EPD, Embolic protection device; PTA, percutaneous transluminal angioplasty.

a

Accunet vs Emboshield vs others.

b

Abbott, Abbott Park, Ill.

c

Two patients with stroke had missing stent length and one patient had missing type of EPD.

d

Accunet vs others.